Mitchell Leibowitz and Rina Sakata

Mitchell Leibowitz, Pellman Lab, DFCI. 

Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing, BioRxiv, 2020

Rina Sakata, Yachie lab, University of British Columbia.

Base editors for simultaneous introduction of C-to-T and A-to-G mutations, Nature Biotechnology, 2020

Recording: https://harvard.zoom.us/rec/share/dxdgaL1qxR25UrJ5-v_HOK_8_jCTp_391YsUr…